Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders
Clinical Relevance and Human Trials Clinical trials have explored the administration of BPC 157 at a dosage of 200 g per person per day via intramuscular injection for a duration of 7 days
Pre-clinical research conducted primarily in animal models informs the hypotheses for its use, but no large randomized controlled trials in humans have confirmed efficacy for any outcome - including gut-lining support, tissue-related processes, or any other claimed mechanism
A 2025 Phase I trial (Lee & Burgess, 2025) demonstrated that IV BPC-157 doses up to 20 mg were tolerated in healthy volunteers with no serious adverse events
Some women report that supplementing with prescription sermorelin and boosting HGH can lead to several benefits, including improved energy levels, metabolism, fat loss, and overall feelings of well-being